| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |